<DOC>
	<DOC>NCT02101359</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and safety assessment of T2380 for mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group (topical mydriatics and anaesthetic) 2X246 patients.</brief_summary>
	<brief_title>Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery</brief_title>
	<detailed_description>In order to perform pupil size measurements and ocular discomfort assessments at specific times, the surgical procedure was divided into 5 time periods according to the following time points: T1 (just before first incision), T2 (just before viscoelastic injection), T3 (just before capsulorhexis), T4 (just before intraocular lens injection), and T5 (just before cefuroxime injection).</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<mesh_term>Tropicamide</mesh_term>
	<criteria>Signed and dated informed consent Male or female aged from 40 to 88 years old Scheduled to undergo unilateral cataract surgery Exclusion criteria: Combined surgery Previous intraocular surgery</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>88 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>